130 related articles for article (PubMed ID: 12470879)
1. Effects of excitotoxic lesions of the central or basolateral nucleus of the amygdala on naloxone-precipitated withdrawal-induced conditioned place aversion in morphine-dependent rats.
Watanabe T; Yamamoto R; Maeda A; Nakagawa T; Minami M; Satoh M
Brain Res; 2002 Dec; 958(2):423-8. PubMed ID: 12470879
[TBL] [Abstract][Full Text] [Related]
2. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats.
Nakagawa T; Yamamoto R; Fujio M; Suzuki Y; Minami M; Satoh M; Kaneko S
Neuroscience; 2005; 134(1):9-19. PubMed ID: 15939543
[TBL] [Abstract][Full Text] [Related]
4. Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Psychopharmacology (Berl); 2003 Oct; 170(1):80-8. PubMed ID: 12768272
[TBL] [Abstract][Full Text] [Related]
5. [Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats].
Ishida S; Shimosaka R; Kawasaki Y; Jin C; Kitamura Y; Araki H; Sendo T; Gomita Y
Yakugaku Zasshi; 2008 Mar; 128(3):395-403. PubMed ID: 18311059
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
[TBL] [Abstract][Full Text] [Related]
7. Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion.
Gracy KN; Dankiewicz LA; Koob GF
Neuropsychopharmacology; 2001 Feb; 24(2):152-60. PubMed ID: 11120397
[TBL] [Abstract][Full Text] [Related]
8. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.
Frenois F; Cador M; Caillé S; Stinus L; Le Moine C
Eur J Neurosci; 2002 Oct; 16(7):1377-89. PubMed ID: 12405997
[TBL] [Abstract][Full Text] [Related]
9. CB₁ receptor antagonism in the bed nucleus of the stria terminalis interferes with affective opioid withdrawal in rats.
Wills KL; DeVuono MV; Limebeer CL; Vemuri K; Makriyannis A; Parker LA
Behav Neurosci; 2017 Aug; 131(4):304-11. PubMed ID: 28714716
[TBL] [Abstract][Full Text] [Related]
10. Effects of inactivating the agranular or granular insular cortex on the acquisition of the morphine-induced conditioned place preference and naloxone-precipitated conditioned place aversion in rats.
Li CL; Zhu N; Meng XL; Li YH; Sui N
J Psychopharmacol; 2013 Sep; 27(9):837-44. PubMed ID: 23784741
[TBL] [Abstract][Full Text] [Related]
11. α7 Nicotinic acetylcholine receptors in the central amygdaloid nucleus alter naloxone-induced withdrawal following a single exposure to morphine.
Ishida S; Kawasaki Y; Araki H; Asanuma M; Matsunaga H; Sendo T; Kawasaki H; Gomita Y; Kitamura Y
Psychopharmacology (Berl); 2011 Apr; 214(4):923-31. PubMed ID: 21125398
[TBL] [Abstract][Full Text] [Related]
12. Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine.
McDonald RV; Parker LA; Siegel S
Pharmacol Biochem Behav; 1997 Dec; 58(4):1003-8. PubMed ID: 9408206
[TBL] [Abstract][Full Text] [Related]
13. Double Dissociation of Monoacylglycerol Lipase Inhibition and CB1 Antagonism in the Central Amygdala, Basolateral Amygdala, and the Interoceptive Insular Cortex on the Affective Properties of Acute Naloxone-Precipitated Morphine Withdrawal in Rats.
Wills KL; Petrie GN; Millett G; Limebeer CL; Rock EM; Niphakis MJ; Cravatt BF; Parker LA
Neuropsychopharmacology; 2016 Jun; 41(7):1865-73. PubMed ID: 26647976
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 5-HT neurotransmission increases clonidine protective effects on naloxone-induced conditioned place aversion in morphine-dependent rats.
Caillé S; Stinus L; Espejo EF; De Deurwaerdère P; Spampinato U; Koob GF
Neuropsychopharmacology; 2003 Feb; 28(2):276-83. PubMed ID: 12589380
[TBL] [Abstract][Full Text] [Related]
15. The involvement of CRF1 receptor within the basolateral amygdala and dentate gyrus in the naloxone-induced conditioned place aversion in morphine-dependent mice.
Valero E; Gómez-Milanés I; Almela P; Ribeiro Do Couto B; Laorden ML; Milanés MV; Núñez C
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):102-114. PubMed ID: 29407532
[TBL] [Abstract][Full Text] [Related]
16. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal.
Kosten TA
Eur J Pharmacol; 1994 Mar; 254(1-2):59-63. PubMed ID: 8206117
[TBL] [Abstract][Full Text] [Related]
17. Effects of exogenous cholecystokinin octapeptide on acquisition of naloxone precipitated withdrawal induced conditioned place aversion in rats.
Yu H; Wen D; Ma C; Meng Y; Li S; Ni Z; Cong B
PLoS One; 2012; 7(7):e41860. PubMed ID: 22848639
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of beta-adrenergic receptor antagonism in basolateral amygdala on reconsolidation of aversive and appetitive memories associated with morphine in rats.
Wu Y; Li Y; Yang X; Sui N
Addict Biol; 2014 Jan; 19(1):5-15. PubMed ID: 22458530
[TBL] [Abstract][Full Text] [Related]
19. Morphine withdrawal syndrome: differential participation of structures located within the amygdaloid complex and striatum of the rat.
Calvino B; Lagowska J; Ben-Ari Y
Brain Res; 1979 Nov; 177(1):19-34. PubMed ID: 574050
[TBL] [Abstract][Full Text] [Related]
20. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release.
Spanagel R; Almeida OF; Bartl C; Shippenberg TS
Psychopharmacology (Berl); 1994 Jun; 115(1-2):121-7. PubMed ID: 7862883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
